Global Antihypertensive Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antihypertensive Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Antihypertensive drug is a kind of medicine that can control blood pressure and is used to treat hypertension.
Antihypertensive Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antihypertensive Drugs market is projected to reach US$ 41290 million in 2034, increasing from US$ 32770 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from The Old and Pregnant Woman are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antihypertensive Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antihypertensive Drugs key manufacturers include Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, Astra Zeneca and Daiichi Sankyo, etc. Novartis, Pfizer, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Antihypertensive Drugs can be divided into Diuretic Antihypertensive, Sympathetic Suppressant, Renin-angiotensin System Inhibitor and Calcium Antagonist Medicine, etc. Diuretic Antihypertensive is the mainstream product in the market, accounting for % sales share globally in 2022.
Antihypertensive Drugs is widely used in various fields, such as The Old, Pregnant Woman and General Patient,, etc. The Old provides greatest supports to the Antihypertensive Drugs industry development. In 2022, global % sales of Antihypertensive Drugs went into The Old filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antihypertensive Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics
Segment by Type
Diuretic Antihypertensive
Sympathetic Suppressant
Renin-angiotensin System Inhibitor
Calcium Antagonist Medicine
vasodilator
The Old
Pregnant Woman
General Patient
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antihypertensive Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antihypertensive Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antihypertensive Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antihypertensive Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antihypertensive Drugs introduction, etc. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antihypertensive Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Antihypertensive Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antihypertensive Drugs market is projected to reach US$ 41290 million in 2034, increasing from US$ 32770 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from The Old and Pregnant Woman are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antihypertensive Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antihypertensive Drugs key manufacturers include Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, Astra Zeneca and Daiichi Sankyo, etc. Novartis, Pfizer, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Antihypertensive Drugs can be divided into Diuretic Antihypertensive, Sympathetic Suppressant, Renin-angiotensin System Inhibitor and Calcium Antagonist Medicine, etc. Diuretic Antihypertensive is the mainstream product in the market, accounting for % sales share globally in 2022.
Antihypertensive Drugs is widely used in various fields, such as The Old, Pregnant Woman and General Patient,, etc. The Old provides greatest supports to the Antihypertensive Drugs industry development. In 2022, global % sales of Antihypertensive Drugs went into The Old filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antihypertensive Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics
Segment by Type
Diuretic Antihypertensive
Sympathetic Suppressant
Renin-angiotensin System Inhibitor
Calcium Antagonist Medicine
vasodilator
Segment by Application
The Old
Pregnant Woman
General Patient
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antihypertensive Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antihypertensive Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antihypertensive Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antihypertensive Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antihypertensive Drugs introduction, etc. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antihypertensive Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices